Regenerative Medicine News in Tijuana
Stem Cell Science & Patient Education
Muse Cell Therapy Shows Promise in Phase II Stroke Recovery Trial
A landmark Phase II clinical trial published in the New England Journal of Medicine demonstrates significant neurological recovery in ischemic stroke patients treated with Muse cells within 90 days of onset.
LIV Expands NK Cell Therapy Protocol to Include Post-COVID Recovery
Following compelling outcomes in our patient cohort, LIV's medical team has formalized a Natural Killer Cell Therapy protocol specifically designed for long-COVID immune dysregulation.
The Rise of Medical Tourism: Why Americans Are Crossing the Border for Regenerative Care
A new report from the Medical Tourism Association estimates that over 1.4 million Americans sought medical care in Mexico in 2024, with regenerative medicine among the fastest-growing categories.
Mesenchymal Stem Cells in Rheumatoid Arthritis: A Systematic Review
A comprehensive meta-analysis of 24 clinical trials confirms the efficacy of MSC therapy in reducing disease activity scores and inflammatory markers in refractory rheumatoid arthritis.
NAD+ and Longevity: What the Latest Research Tells Us
Emerging research from Harvard and the Salk Institute continues to reinforce the role of NAD+ in cellular energy metabolism, DNA repair, and healthy aging. Here's what it means for your health.
LIV Introduces Exosome Therapy for Advanced Facial Rejuvenation
Our aesthetics team has integrated next-generation exosome therapy into our facial rejuvenation protocols, offering patients a non-surgical option for deep skin regeneration and anti-aging.